Bayer Aktiengesellschaft (BAYRY)
OTCMKTS · Delayed Price · Currency is USD
13.16
+0.36 (2.81%)
Oct 29, 2026, 11:42 AM EDT
Bayer Aktiengesellschaft Market Cap
Bayer Aktiengesellschaft has a market cap or net worth of $51.82 billion as of October 29, 2026. Its market cap has increased by 64.82% in one year.
Market Cap
51.82B
Enterprise Value
89.13B
Revenue
51.84B
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since January 1, 1992, Bayer Aktiengesellschaft's market cap has increased from 5.86B to 51.82B, an increase of 784.31%. That is a compound annual growth rate of 6.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 51.82B | 21.16% |
| Dec 30, 2025 | 42.77B | 117.25% |
| Dec 30, 2024 | 19.69B | -46.09% |
| Dec 29, 2023 | 36.52B | -28.02% |
| Dec 30, 2022 | 50.74B | -2.95% |
| Dec 30, 2021 | 52.28B | -10.07% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 1.19B |
| Veradigm | 808.86M |
| American Oncology Network | 745.50M |
| Nika Pharmaceuticals | 369.14M |
| CytoDyn | 351.58M |
| Northwest Biotherapeutics | 285.69M |
| Elite Pharmaceuticals | 268.42M |
| Glorywin Entertainment Group | 234.77M |